|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| G01N 33/57449 | (2013.01) |
| (11) | Number of the document | 3874274 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19809947.5 |
| Date of filing the European patent application | 2019-10-31 | |
| (97) | Date of publication of the European application | 2021-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/059218 |
| Date | 2019-10-31 |
| (87) | Number | WO 2020/092808 |
| Date | 2020-05-07 |
| (30) | Number | Date | Country code |
| 201862753274 P | 2018-10-31 | US |
| (72) |
ALIFERIS, Konstantinos , US
WINTERHOFF, Boris Jan nils , US
MA, Sisi , US
WANG, Jinhua , US
|
| (73) |
Regents of the University of Minnesota ,
600 McNamara Alumni Center
200 Oak Street SE, Minneapolis, MN 55455-2020,
US
|
| (54) | METHODS FOR PREDICTING A RESPONSE TO BEVACIZUMAB OR PLATINUM-BASED CHEMOTHERAPY OR BOTH IN PATIENTS WITH OVARIAN CANCER |
| METHODS FOR PREDICTING A RESPONSE TO BEVACIZUMAB OR PLATINUM-BASED CHEMOTHERAPY OR BOTH IN PATIENTS WITH OVARIAN CANCER |